BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• BioMidwest

  Case Western Reserve and Sangamo Therapeutics Announce $11M NIH Grant for Study of Gene-Edited T Cells for Viral Eradication of HIV

  The grant will fund a clinical trial to test the hypothesis that treating patients with their own gene-edited T cells may lead to a sustained increase in T cell counts and eradication of latent HIV reservoirs.

  February 7, 2018

   · 

  5 min read
• Sanofi Delivers 2017 Business EPS in Line With Guidance

  Fourth-quarter and 2017 accounts reflect the acquisition of the former Boehringer Ingelheim CHC business and the disposal of the Animal Health business.

  February 7, 2018

   · 

  12 min read
• Pharm Country

  Eagle Pharmaceuticals Announces Fifth Orange Book Listed Patent for RYANODEX

  Eagle today announced that the Company has been issued a new patent related to its RYANODEX product (dantrolene sodium for injectable suspension) by the United States Patent and Trademark Office (USPTO).

  February 7, 2018

   · 

  4 min read
• 

  Drug Development

  Biogen Halts Plans to Develop Tysabri for Stroke After Phase IIb Trial Flop

  Natalizumab did not demonstrate improvement in clinical outcomes compared to placebo.

  February 7, 2018

   · 

  6 min read
• Biotech Beach

  Nasdaq Grants BIOLASE 180-Day Extension to Meet Minimum Bid Price Requirement

  As previously disclosed, BIOLASE received notice from Nasdaq on August 9, 2017, that it was not in compliance with the Bid Price Requirements for its common stock.

  February 7, 2018

   · 

  3 min read
• Business

  UNITY Biotech Adds Accomplished R&D Leader David L. Lacey, M.D., to Board of Directors

  Dr. Lacey brings to UNITY more than 30 years of experience in medical research, including a 17-year tenure at Amgen leading research across multiple disease areas.

  February 7, 2018

   · 

  2 min read
• Business

  AtriCure to Announce Fourth Quarter and Full Year 2017 Financial Results

  AtriCure will host a conference call at 4:30 p.m. Eastern Time on Monday, February 26, 2018 to discuss its fourth quarter and full year 2017 financial results.

  February 7, 2018

   · 

  1 min read
• Lone Star Bio

  US Bioservices Announces Record Breaking Year for New Business Wins in Rare & Orphan, Oncology and Specialty Infusion

  US Bioservices announced that 2017 was a record breaking year for new business wins in three strategic areas – oncology, rare and orphan and specialty infusion.

  February 7, 2018

   · 

  4 min read
• Drug Development

  Xcovery Announces Initiation of Phase II Clinical Trial for Ensartinib in Melanoma Patients with ALK Alternations

  The trial is being conducted by the renowned Memorial Sloan Kettering Cancer Center (MSK) and led by MSK’s Dr. Alexander Shoushtari.

  February 7, 2018

   · 

  3 min read
• Biotech Bay

  Exelixis Announces Updated Phase 1 Trial Results for Cabozantinib in Combination with Nivolumab with or without Ipilimumab in Refractory Genitourinary (GU) Tumors

  The primary endpoint of the trial is to determine the dose-limiting toxicity and recommended phase 2 doses of the doublet and triplet combinations.

  February 7, 2018

   · 

  17 min read